- Home
- BLLN vs BOOT Comparison
BLLN vs BOOT Comparison
Compare BLLN & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLLN | BOOT |
|---|---|---|
| Founded | 2016 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BLLN | BOOT |
|---|---|---|
| Price | $109.83 | $137.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 17 |
| Target Price | $129.00 | ★ $180.67 |
| AVG Volume (30 Days) | 456.0K | ★ 870.2K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.40 | 25.00 |
| EPS | 0.48 | ★ 4.02 |
| Revenue | $305,112,000.00 | ★ $776,854,000.00 |
| Revenue This Year | $49.33 | $14.57 |
| Revenue Next Year | $26.38 | $12.58 |
| P/E Ratio | $237.01 | ★ $32.75 |
| Revenue Growth | ★ 99.97 | 14.59 |
| 52 Week Low | $61.96 | $110.53 |
| 52 Week High | $150.44 | $210.25 |
Technical Indicators
Market Signals| Indicator | BLLN | BOOT |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 64.72 |
| Support Level | $89.26 | $135.35 |
| Resistance Level | $127.72 | $170.63 |
| Average True Range (ATR) | 5.53 | 6.13 |
| MACD | 1.15 | 2.99 |
| Stochastic Oscillator | 60.41 | 95.89 |
Price Performance
Historical ComparisonAbout BLLN BillionToOne Inc.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores that sell western and work boots and related apparel and accessories. The Company operates retail locations throughout the U.S. and sells its merchandise via the Internet. The Company operates a total of approximately 539 stores in 49 states. All stores operated under the Boot Barn name.